All Stories

  1. Predictors of Cognitive-Behavioral Therapy for insomnia (CBT-I) outcomes in individuals with psychiatric disorders: A Retrospective Observational Cohort Study
  2. Correction: Acceptability of Health Information Technology by Health Care Professionals: Where We Are Now and How We Can Fill the Gap
  3. Association between sleep disturbances and suicidal thoughts in a large sample of university students
  4. A large-scale study of Chronic Sleep Disorders in Psychiatric Inpatients: prevalence, hospitalization burden, restraint use, and comorbidities
  5. A study on electroretinography as a biomarker for seasonal vulnerability in depression
  6. Nonrestorative Sleep: A simple question with major consequences - A call to integrate sleep health in preventive medicine
  7. Napping and psychiatric disorders: a systematic review.
  8. Proposition of a new, minimally-invasive, software smartphone device to predict sleep apnea and its severity
  9. Association between sleep complaints and quality of life and the mediating role of substance use disorders: results from a nationally representative sample
  10. Sleep and Dreams as Reflected by Science Fiction Literature and Films—Anything to Learn From?
  11. Burning the diagnosis: When burn-out masks psychiatric and sleep disorders
  12. Investigating circadian patterns in electrochemical skin Conductance: A year-long retrospective analysis using home-based devices
  13. Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force
  14. Management of Insomnia Complaints by Non‐Sleep Specialist Physicians: A French DELPHI Consensus
  15. Screening and evaluating seasonal affective disorder: a systematic review of available assessment tools
  16. Validation of the French version of the Insomnia Severity Index in a population with psychiatric disorders and sleep complaints
  17. Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development
  18. Evaluation of a Contactless Sleep Monitoring Device for Sleep Stage Detection against Home Polysomnography in a Healthy Population
  19. Evaluation of a Contactless Sleep Monitoring Device for Sleep Stage Detection against Home Polysomnography in a Healthy Population (Preprint)
  20. Evaluation of a Contactless Sleep Monitoring Device for Sleep Stage Detection at Home in a Healthy Population: A Prospective Study in Free Living Conditions (Preprint)
  21. Chronobiology of Mood Disorders: The Role of the Biological Clock in Depression and Bipolar Disorder
  22. Increased sleep duration and emotional regulation in patients with major depressive episodes
  23. L’absence d’examen physique par le psychiatre n’est pas éthique
  24. Acceptability of Health Information Technology by Healthcare Professionals: where are we now and how can we fill the gap? (Preprint)
  25. Pupillary response to blue light as a biomarker of seasonal pattern in Major Depressive Episode: A clinical study using pupillometry
  26. Cerebral blood flow in attention deficit hyperactivity disorder: A systematic review
  27. Sex differences in insomnia and hypersomnia complaints during major depressive episode: Results from a national sample
  28. Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development (Preprint)
  29. States of consciousness and interoceptive hypersensibility: A study in patients with insomnia disorder
  30. Insomnia and circadian rhythms dysregulation in people who have attempted suicide: correlations with markers of inflammation and suicidal lethality
  31. The electroretinography to identify biomarkers of idiopathic hypersomnia and narcolepsy type 1
  32. Study of the different sleep disturbances during the prodromal phase of depression and mania in bipolar disorders
  33. Comparative study of sleep and circadian rhythms in patients presenting unipolar or bipolar major depressive episodes
  34. Lower risk of hospitalisation for depression following hospitalisation for COVID-19 versus for another reason
  35. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
  36. Exploring seasonality in catatonia diagnosis: Evidence from a large-scale population study
  37. Content analysis of insomnia questionnaires: A step to better evaluate the complex and multifaceted construct of insomnia disorder
  38. Major depressive episode with insomnia and excessive daytime sleepiness: A more homogeneous and severe subtype of depression
  39. Predictors of cognitive behavioral therapy for insomnia (CBT-I) effects in insomnia with major depressive episode
  40. The nightmare severity index (NSI): A short new multidimensional tool for assessing nightmares
  41. Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches
  42. Dark skies before the storm: The Chronos syndrome
  43. Efficacy of melatonin and ramelteon for the acute and long‐term management of insomnia disorder in adults: A systematic review and meta‐analysis
  44. How are you dreaming? A very simple question to screen for suicide risk
  45. Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort
  46. Sleep Deprivation and Insomnia in Adolescence: Implications for Mental Health
  47. Emotional Exhaustion, a Proxy for Burnout, Is Associated with Sleep Health in French Healthcare Workers without Anxiety or Depressive Symptoms: A Cross-Sectional Study
  48. Continuous positive airway pressure as an accurate marker for non‐24‐hour sleep–wake rhythm disorder
  49. Sleep quality of medical students and relationships with academic performances
  50. Systematic Item Content and Overlap Analysis of Self-Reported Multiple Sleep Disorder Screening Questionnaires in Adults
  51. Sleep Complaints Among Adults With Major Depressive Episode Are Associated With Increased Risk of Incident Psychiatric Disorders
  52. A comparison of four methods to estimate dim light melatonin onset: a repeatability and agreement study
  53. Bad Dreams and Nightmares Preceding Suicidal Behaviors
  54. A cross‐sectional study: Nitrous oxide abuse in Parisian medical students
  55. Factors associated with insomnia symptoms: A cross‐sectional study during a Covid‐19 fully restrictive lockdown
  56. The “GHU-Checkist”: Validity and acceptability of a 17-words checklist for rapid screening of depressive symptoms and anxiety
  57. Sleep Markers in Psychiatry: Do Insomnia and Disturbed Sleep Play as Markers of Disrupted Neuroplasticity in Mood Disorders? A Proposed Model
  58. Gender-related associations between psychiatric disorders and alcohol use disorder: Findings from the french “Mental health in the general population” survey
  59. Association between polarity of first episode and solar insolation in bipolar I disorder
  60. A Systematic Review of Sleep–Wake Disorder Diagnostic Criteria Reliability Studies
  61. How Can Digital Mental Health Enhance Psychiatry?
  62. The melanopsin-mediated pupil response is reduced in idiopathic hypersomnia with long sleep time
  63. Seasonal changes and decrease of suicides and suicide attempts in France over the last 10 years
  64. Insomnia evaluation and treatment during peripartum: a joint position paper from the European Insomnia Network task force “Sleep and Women,” the Italian Marcè Society and international experts task force for perinatal mental health
  65. Neurologic Outcomes of Survivors of COVID-19–Associated Acute Respiratory Distress Syndrome Requiring Intubation
  66. Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study
  67. Multi-Level Processes and Retina–Brain Pathways of Photic Regulation of Mood
  68. A study of nightmares in patients with psychiatric disorders
  69. Sleep disturbances in early clinical stages of psychotic and bipolar disorders: A meta-analysis
  70. Impact of meteorological factors on alcohol use disorders: A study in emergency departments
  71. Tobacco-induced sleep disturbances: A systematic review and meta-analysis
  72. Seasonal Changes and Decrease of Suicides and Suicide Attempts in France Over the Last 10 Years”.
  73. Investigating racing thoughts in insomnia: A neglected piece of the mood-sleep puzzle?
  74. Why do sleep disorders belong to mental disorder classifications? A network analysis of the “Sleep-Wake Disorders” section of the DSM-5
  75. Sleep and circadian rhythm characteristics in individuals from the general population during the French COVID‐19 full lockdown
  76. Polysomnography in seasonal affective disorder: A systematic review and meta-analysis
  77. Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder
  78. Efficacy and safety of topiramate for reducing impulsivity: A transdiagnostic systematic review and meta‐analysis of a common clinical use
  79. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration
  80. Symptom network analysis of the sleep disorders diagnostic criteria based on the clinical text of the ICSD‐3
  81. Correction to: Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population
  82. International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders
  83. The Effects of Transcranial Electrical Stimulation of the Brain on Sleep: A Systematic Review
  84. Validity and Usage of the Seasonal Pattern Assessment Questionnaire (SPAQ) in a French Population of Patients with Depression, Bipolar Disorders and Controls
  85. Early Life Stress and Chronobiological Rhythms Desynchronization
  86. Use of immediate release melatonin in psychiatry: BMI impacts the daily-dose
  87. Des gènes circadiens à la sémiologie psychiatrique
  88. Biological rhythms and chronotherapeutics in depression
  89. Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population
  90. Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19
  91. Predictors of Suicidal Ideation and Preparatory Behaviors in Individuals With Bipolar Disorder
  92. Insomnia, sleep loss and circadian sleep disturbances in mood disorders: a pathway toward neurodegeneration and neuroprogression? A theoretical review
  93. Sadness and the continuum from well-being to depressive disorder: Findings from a representative US population sample
  94. Nightmares in Patients with Major Depressive Disorder, Bipolar Disorder, and Psychotic Disorders: A Systematic Review
  95. Misperception of sleep in bipolar disorder: an exploratory study using questionnaire versus actigraphy
  96. Lightening depression
  97. Recent Stressful Life Events in Euthymic Major Depressive Disorder Patients: Sociodemographic and Clinical Characteristics
  98. Depression with and without a history of psychotic symptoms in the general population: sociodemographic and clinical characteristics
  99. Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self‐report approaches
  100. A Latent Class Analysis of Manic and Psychotic Symptoms
  101. The Light of Hope in Antidepressant Strategies
  102. Activity, cognition, and emotion: Three dimensional pillars of the natural presentations of mood disorders enriched by the “sleep” fourth dimension (ACES)
  103. Conséquences psychopathologiques du confinement
  104. Psychological Support System for Hospital Workers During the Covid-19 Outbreak: Rapid Design and Implementation of the Covid-Psy Hotline
  105. Efficacy of tDCS for bipolar depression in a patient with spinocerebellar ataxia: A case report
  106. Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III)
  107. Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study
  108. Standardized Patients or Conventional Lecture for Teaching Communication Skills to Undergraduate Medical Students: A Randomized Controlled Study
  109. Intérêts d’un atelier de simulation avec des patients standardisés pour la formation à l’examen du risque suicidaire
  110. Alterations in circadian rhythms following alcohol use: A systematic review
  111. Inhibition of Phytosterol Biosynthesis by Azasterols
  112. Association between coffee, tobacco, and alcohol daily consumption and sleep/wake cycle: an actigraphy study in euthymic patients with bipolar disorders
  113. Hopelessness and its correlates with clinical outcomes in an outpatient setting
  114. Alexithymia as a possible specifier of adverse outcomes: Clinical correlates in euthymic unipolar individuals
  115. Management of insomnia in alcohol use disorder
  116. Functional Motor Symptoms in Parkinson’s Disease and Functional Parkinsonism: A Systematic Review
  117. Light therapy with boxes or glasses to counteract effects of acute sleep deprivation
  118. Efficacy of light therapy versus antidepressant drugs, and of the combination versus monotherapy, in major depressive episodes: A systematic review and meta-analysis
  119. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology
  120. Eveningness and poor sleep quality contribute to depressive residual symptoms and behavioral inhibition in patients with bipolar disorder
  121. The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS)
  122. Alcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study
  123. An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes
  124. Plastic Adaptation to Pathology in Psychiatry: Are Patients with Psychiatric Disorders Pathological Experts?
  125. Metabolic engineering of Chinese hamster ovary cells towards reduced biosynthesis and accumulation of novel growth inhibitors in fed-batch cultures
  126. Does childhood experience of attention-deficit hyperactivity disorder symptoms increase sleep/wake cycle disturbances as measured with actigraphy in adult patients with bipolar disorder?
  127. Light Therapy in Mood Disorders: A Brief History with Physiological Insights
  128. Bright light therapy improved sleep disturbances in a patient with dementia with Lewy bodies
  129. Bright Light as a Personalized Precision Treatment of Mood Disorders
  130. Which actigraphic variables optimally characterize the sleep-wake cycle of individuals with bipolar disorders?
  131. In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes
  132. Environment risk factors have different impact on bipolar and psychotic disorders: an analysis of MHGP survey
  133. Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial
  134. Two Manic Episodes Related to a Levetiracetam-Based Treatment in a 34-Year-Old Female Patient
  135. Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial
  136. The Plastic Adaptation to Pathology in Psychiatry. Are Patients with Psychiatric Disorders Pathological Experts?
  137. Clock Genes and Light Signaling Alterations in Bipolar Disorder: When the Biological Clock Is Off
  138. Vitamin D5 in Arabidopsis thaliana
  139. Clinical characteristics of obstructive sleep apnea in bipolar disorders.
  140. Aux frontières de la sémiologie psychiatrique !
  141. Sleep and circadian rhythms as possible trait markers of suicide attempt in bipolar disorders: an actigraphy study
  142. More comprehensive models are needed to understand how relative amplitude might affect wellbeing and risk of mood disorders
  143. Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patients
  144. Determination of sets of covariating gene expression using graph analysis on pairwise expression ratios
  145. The neurobiology of adaptation to seasons: Relevance and correlations in bipolar disorders
  146. Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study
  147. Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission
  148. The Impact of Transcranial Direct Current Stimulation (tDCS) on Bipolar Depression, Mania, and Euthymia: a Systematic Review of Preliminary Data
  149. Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the ‘Mental Health in General Population’ (MHGP) survey
  150. Increased prevalence of anxiety disorders in third-generation migrants in comparison to natives and to first-generation migrants
  151. Light treatment in depression: an antique treatment with new insights
  152. Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey
  153. L’application DICOSEMIOPSY ©  : un lexique de sémiologie psychiatrique illustré
  154. A study in the general population about sadness to disentangle the continuum from well-being to depressive disorders
  155. Insomnia and hypersomnia in major depressive episode: Prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study
  156. A latent class analysis of psychotic symptoms in the general population
  157. Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis
  158. Irritable temperament and lifetime psychotic symptoms as predictors of anxiety symptoms in bipolar disorder
  159. Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE-BD])
  160. Transcranial direct-current stimulation (tDCS) for bipolar depression: A systematic review and meta-analysis
  161. Very early hallucinatory experiences: a school‐based study
  162. La sémiologie motrice en psychiatrie : une dimension oubliée !
  163. Les maladies neurologiques à expression psychiatrique : importance de l’examen neurologique
  164. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort
  165. Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder
  166. Alcohol Use Disorders and Immigration up to the Third Generation in France: Findings from a 39,617-Subject Survey in the General Population
  167. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders
  168. Prodrome or risk syndrome: what’s in a name?
  169. Prevalence and clinical severity of mood disorders among first-, second- and third-generation migrants
  170. Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder
  171. Lithium response in bipolar disorders and core clock genes expression
  172. Cross-validation of clinical characteristics and treatment patterns associated with phenotypes for lithium response defined by the Alda scale
  173. Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders
  174. Influence of lithium on sleep and chronotypes in remitted patients with bipolar disorder
  175. The RANZCP mood disorders guidelines: An easy step-by-step toolbox for daily practice
  176. Comment caractériser et traiter les plaintes de sommeil dans les troubles bipolaires ?
  177. Clinical factors associated with lithium response in bipolar disorders
  178. Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1α) and RORA
  179. Does baclofen have antidepressant qualities?
  180. Factors Affecting the Agreement Between Emergency Psychiatrists and General Practitioners Regarding Involuntary Psychiatric Hospitalizations
  181. Lithium and suicide prevention in bipolar disorder
  182. Le boucher du Prince Wen-houei. De l’art médical du recueil sémiologique valide en psychiatrie
  183. Encéphalopathie mitochondriale neuro-gastro-intestinale (MNGIE) : quand et comment l’évoquer devant une anorexie mentale atypique ?
  184. How Anti-NMDAR Encephalitis Sheds Light on the Mechanisms Underlying Catatonia: The Neural Excitatory/Inhibitory Imbalance Model
  185. Seasonal Influence on Mass Shootings
  186. De « Psychose maniaco-dépressive » à « Troubles bipolaires » : une histoire des représentations sociales et de la stigmatisation en rapport avec la nosographie
  187. Psychiatrie du sujet âgé en milieu pénitentiaire
  188. Course of residual symptoms according to the duration of euthymia in remitted bipolar patients
  189. Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms
  190. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways
  191. Extreme sensory processing patterns and their relation with clinical conditions among individuals with major affective disorders
  192. The bidirectional relation between emotional reactivity and sleep: From disruption to recovery.
  193. Luminothérapie et épisodes dépressifs saisonniers du trouble bipolaire
  194. Effet des saisons sur la sémiologie des troubles bipolaires
  195. La sémiologie psychiatrique éclairée par les neurosciences
  196. Saisons, rythmes circadiens, sommeil et vulnérabilité aux conduites suicidaires
  197. Keep calm: Psychiatric disorders are organic! The power of words in medicine
  198. Catatonia and cannabis withdrawal: A case report
  199. Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
  200. Melatonin in Bipolar Disorders
  201. Le jardinier et le botaniste. Proposition d’une organisation minimale de la sémiologie psychiatrique pour l’étudiant en médecine
  202. Genetic association study of circadian genes with seasonal pattern in bipolar disorders
  203. Syndrome catatonique précoce et encéphalite à auto-anticorps antirécepteurs-NMDA : une mise au point
  204. Individuals With Bipolar Disorder and Their Relationship With the Criminal Justice System: A Critical Review
  205. Effects of Clozapine on Perceptual Abnormalities and Sensory Gating
  206. Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder
  207. Reply: Sleep in Patients with Remitted Bipolar Disorders: Analyses stratified on actigraphy devices, age and gender
  208. Prédire le trouble bipolaire : que pouvons-nous apprendre des études prospectives de cohortes ?
  209. Trouble bipolaire de l’humeur : effet des sels de lithium sur les rythmes circadiens
  210. Links between sleep and body mass index in bipolar disorders: An exploratory study
  211. Voyage et troubles psychotiques : clinique et recommandations pratiques
  212. Les anomalies du sommeil peuvent-elles participer au risque cardio-vasculaire des troubles bipolaires ?
  213. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies
  214. EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials
  215. Sciences et psychiatrie
  216. Seasonality and bipolar disorder: A systematic review, from admission rates to seasonality of symptoms
  217. The arcuate fasciculus in auditory-verbal hallucinations: A meta-analysis of diffusion-tensor-imaging studies
  218. Brain changes in early-onset bipolar and unipolar depressive disorders: a systematic review in children and adolescents
  219. Le trouble bipolaire chez l’enfant et l’adolescent : un diagnostic difficile
  220. Traitement du trouble bipolaire en phase maniaque : synthèse critique des recommandations internationales
  221. Baclofen-Induced Manic Symptoms: Case Report and Systematic Review
  222. État actuel de la formation des médecins généralistes à la psychiatrie et à la santé mentale en France
  223. Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response
  224. Sleep in remitted bipolar disorder: A naturalistic case-control study using actigraphy
  225. Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder
  226. Somatotopy and bodily hallucinations
  227. Antipsychotics Management in Addictive Disorders
  228. État actuel de la formation des médecins généralistes à la psychiatrie et à la santé mentale en France
  229. Can the response to mood stabilizers be predicted in bipolar disorder
  230. An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: a pilot study
  231. Épisodes dépressifs mixtes : clinique et biomarqueurs neurophysiologiques
  232. Personnalité normale et pathologique au cours du vieillissement : diagnostic, évolution, et prise en charge
  233. Kleine-Levin syndrome and bipolar disorder: a differential diagnosis of recurrent and resistant depression
  234. Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset
  235. Bipolar Disorder with Seasonal Pattern: Clinical Characteristics and Gender Influences
  236. Chronotypes of Bipolar Patients in Remission: Validation of the French Version of the Circadian Type Inventory in the FACE-BD Sample
  237. Gestion des traitements de substitution aux opiacés lorsqu’un antalgique est indiqué
  238. Corrélats anatomofonctionnels du syndrome d’Ekbom
  239. Gene X Environment Interactions in Schizophrenia and Bipolar Disorder: Evidence from Neuroimaging
  240. Abstinence dans l’alcoolodépendance : approche critique et actualisée des recommandations nationales de 2001
  241. Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals
  242. Génétique des hallucinations : des voix pas sans gène !
  243. Combination Therapy for Manic Phases: A Critical Review of a Common Practice
  244. Une entité clinique aux implications thérapeutiques majeures : le trouble bipolaire à début précoce
  245. Fibromyalgie et psychiatrie : 35 ans plus tard… Quoi de neuf ?
  246. Efficacy of Aripiprazole in Comorbid Addiction in Bipolar Disorder
  247. Catatonia and Alcohol Withdrawal: A Complex and Underestimated Syndrome
  248. Génétique des hallucinations : des voix pas sans gène !
  249. Use of Aripiprazole in Treatment of Cannabis Dependence in a Patient Presenting With Borderline Personality Disorder
  250. Shared vulnerability between seizures and psychosis in cocaine addiction?